The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are ...

Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an ...

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an ...

SBI Securities Co. Ltd. purchased a new position in VanEck Biotech ETF (NASDAQ:BBH – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Legend Biotech (LEGN – Research Report) today. The company’s shares ...

Ieq Capital LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

The Fund seeks to track the investment results of the Dynamic Biotech & Genome Intellidex. The Fund generally will invest at least 90% of its total assets in common stocks of biotechnology ...

the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice ...